513 top medical experts on Frontotemporal Lobar Degeneration across 34 countries and 25 U.S. states, including 402 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Frontotemporal Lobar Degeneration: Heterogeneous group of neurodegenerative disorders characterized by frontal and temporal lobe atrophy associated with neuronal loss, gliosis, and dementia. Patients exhibit progressive changes in social, behavioral, and/or language function. Multiple subtypes or forms are recognized based on presence or absence of TAU protein inclusions. ftld includes three clinical syndromes: frontotemporal dementia, semantic dementia, and primary progressive nonfluent aphasia.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): TDP-43 Proteinopathies (1,249), Dementia (5,282) and Narrower Categories: Frontotemporal Dementia (3,560), Primary Progressive Nonfluent Aphasia (512).
  4. Clinical Trials ClinicalTrials.gov : at least 32 including 2 Active, 17 Completed, 3 Recruiting


  

        

                    


    Computing Expert Listing ...

);